Sahajanand Medical Technologies Limited (SMT) is an Indian medical technology company established in 2001, with its registered office in Surat, Gujarat. The company focuses on the research, development, manufacturing and distribution of advanced medical devices, particularly for cardiovascular and vascular interventions.
Its product portfolio includes coronary stents, drug-eluting stents, coronary balloons, drug-coated balloons, structural heart devices and other specialised medical products. The company serves healthcare providers and medical professionals in India and international markets, supported by manufacturing facilities in India and Thailand. Its focus on research and development supports the development of medical technologies used in minimally invasive cardiovascular procedures.
Key Highlights
- ❤️ Cardiovascular Medical Devices – Focuses on products used in the treatment of cardiovascular conditions.
- 🩺 Vascular Intervention – Offers coronary stents, balloons and other interventional devices.
- 🫀 Structural Heart Solutions – Develops devices for specialised structural heart procedures.
- 🔬 Research & Development – Emphasises innovation and development of advanced medical technologies.
- 🏭 Manufacturing Capabilities – Operates manufacturing facilities in India and Thailand.
- 🌍 International Presence – Supplies medical devices to domestic and overseas markets.
- 🏥 Healthcare Applications – Products support minimally invasive procedures performed by healthcare professionals.
Disclaimer
This article is for informational and educational purposes only and should not be construed as investment advice or a recommendation.
Sahajanand Medical Technologies IPO Timetable
| Particular | Date |
| IPO Open Date | 15 October 2026 |
| IPO Close Date | 19 October 2026 |
| Allotment Date | 22 October 2026 |
| IPO Listing Date | 23 October 2026 |
Sahajanand Medical Technologies IPO Details
| Issue Type | Bookbuilding IPO |
| Face Value | Rs. 1 Per Equity Share |
| IPO Price | Rs. 327 to 344 Per Equity Share |
| Market Lot | 43 Share |
| ISIN Code | INE356Y01018 |
| Listing At | BSE,NSE |
| Issue Size | Rs. 475 Crore. |
Sahajanand Medical Technologies IPO Lot Size
| Application | Lots | Shares | Amount |
| Minimum | 1 | 43 | Rs. 14,792 |
| Maximum | 13 | 559 | Rs. 192,296 |
| Small HNI (Minimum) | 14 | 602 | Rs. 207,088 |
| Big HNI (Minimum) | 68 | 2924 | Rs. 1,005,856 |
Sahajanand Medical Technologies IPO Allotment Status
Click Here To Check IPO Allotment Status Sahajanand Medical Technologies IPO
Click Here To Get ASBA Forms Sahajanand Medical Technologies IPO
Company Financials :
| Particular | Latest Year | Prior Year | 2 Years Prior |
| Total Assets | 1276.43 | 1094.90 | 970.58 |
| Total Revenue | 1218.73 | 1035.96 | 908.59 |
| Profit After Tax | 69.08 | 25.15 | -7.35 |
Company Promoters:
Bhargav Dhirajlal Kotadia, Dhirajlal Vallabhbhai Kotadia, Priyanka Dhirajlal Cohen and Shree Hari Trust.
Registrar & Company Details
| Company Contact Information | IPO Registrar |
| Sahajanand Medical Technologies Ltd. Sahajanand Estate, Wakharia Wadi, NR. Dabholi Char Rasta Nani Ved, Ved Road Surat, Gujarat, 395004 Contact: 022 49564000 Email: investors.grievance@smt.in Web: https://www.smtpl.com/ | MUFG Intime India Private Limited Contact:- +91 810 811 4949 Email:- sahajanandmedical.ipo@in.mpms.mufg.com Web:- https://in.mpms.mufg.com/ |
Risk Disclosure :- Investing in Initial Public Offerings (IPOs) involves significant market risks. The information provided in this blog post is for educational and informational purposes only and should not be treated as investment advice or a recommendation to subscribe to any IPO. Investors must carefully read the Red Herring Prospectus (RHP), company financials, and all risk factors before investing.
IPO allotment is not guaranteed, and the listing price may differ from expectations due to market demand, business fundamentals, and overall market conditions. Newly listed companies may experience high volatility in the initial days of trading. Past performance of other IPOs does not indicate or assure future results.
Investors should evaluate their risk appetite, financial objectives, and seek independent professional advice before making any investment decisions.
🤖 This post has been prepared with the assistance of AI (ChatGPT) for informational and educational purposes only. Readers are advised to verify information through official company sources before making investment decisions.
